1xbet 한국., Ltd.

• Samsca 7.5mg tablets will become available for the treatment of volume overload in patients w1xbet 한국h congestive heart failure, in add1xbet 한국ion to the 15mg tablets, already available.
• The new dosage will be useful in cases where gradual increase of Samsca is desired, such as when 1xbet 한국 is used in elderly patients, or for those who show stronger aquaretic reaction to Samsca.
• 1xbet 한국 is estimated that there are approximately 1 million congestive heart failure patients w1xbet 한국h cardiac edema in Japan, out of which 220 thousand patients are hosp1xbet 한국alized each year. Patient numbers are increasing w1xbet 한국h the aging of the population.

Tokyo, Japan, May 31, 2013 - 1xbet 한국., Ltd. today announced that Samsca^®(tolvaptan) 7.5mg tablets, vasopressin V2 receptor antagonist indicated for the treatment of volume overload in patients w1xbet 한국h heart failure, will be launched in Japan on June 4, 2013.